Author

Zsófia Barcza

Observed names: Z. Barcza, Zsofia Barcza

ORCID: 0000-0001-7708-1994

Observed ORCID: 0000-0001-7708-1994

OpenAlex ID: A5084406752

Nationwide effectiveness of five SARS-CoV-2 vaccines in Hungary—the HUN-VE study

2021 · Zoltán Vokó, Zoltán Kiss, et al. · Clinical Microbiology and Infection · 124

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines During the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)

2022 · Zoltán Kiss, István Wittmann, et al. · Frontiers in Immunology · 46

PDF

Effectiveness and Waning of Protection With Different SARS-CoV-2 Primary and Booster Vaccines During the Delta Pandemic Wave in 2021 in Hungary (HUN-VE 3 Study)

2022 · Zoltán Vokó, Zoltán Kiss, et al. · Frontiers in Immunology · 44

PDF

Different Trends in Excess Mortality in a Central European Country Compared to Main European Regions in the Year of the COVID-19 Pandemic (2020): a Hungarian Analysis

2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 31

PDF

Changing Trends in Melanoma Incidence and Decreasing Melanoma Mortality in Hungary Between 2011 and 2019: A Nationwide Epidemiological Study

2021 · Gabriella Liszkay, Zoltan Kiss, et al. · Frontiers in Oncology · 23

PDF

Lung Cancer in Hungary

2020 · Krisztina Bogos, Zoltán Kiss, et al. · Journal of Thoracic Oncology · 17

PDF

Improvement in breast cancer survival across molecular subtypes in Hungary between 2011 and 2020: a nationwide, retrospective study

2025 · Miklós Darida, Gábor Rubovszky, et al. · Frontiers in Oncology · 13

Improvement in Lung Cancer Survival: 6-Year Trends of Overall Survival at Hungarian Patients Diagnosed in 2011–2016

2021 · Krisztina Bogos, Zoltan Kiss, et al. · Pathology & Oncology Research · 13

PDF

Opposite trends in incidence of breast cancer in young and old female cohorts in Hungary and the impact of the Covid-19 pandemic: a nationwide study between 2011–2020

2023 · Zoltán Kiss, Judit Kocsis, et al. · Frontiers in Oncology · 11

Significant Regional Differences in Lung Cancer Incidence in Hungary: Epidemiological Study Between 2011 and 2016

2021 · Gabriella Gálffy, Aladár Vastag, et al. · Pathology & Oncology Research · 9

Significant improvement in melanoma survival over the last decade: A Hungarian nationwide study between 2011 and 2019

2023 · Gabriella Liszkay, Angela Benedek, et al. · Journal of the European Academy of Dermatology and Venereology · 8

PDF

Significant changes in advanced lung cancer survival during the past decade in Hungary: impact of modern immunotherapy and the COVID-19 pandemic

2023 · Zoltán Kiss, Gabriella Gálffy, et al. · Frontiers in Oncology · 7

Nationwide Effectiveness of First and Second SARS-CoV2 Booster Vaccines during the Delta and Omicron Pandemic Waves in Hungary (HUN-VE 2 Study)

2022 · Zoltán Kiss, István Wittmann, et al. · medRxiv · 7

PDF

Revising cancer incidence in a Central European country: a Hungarian nationwide study between 2011–2019 based on a health insurance fund database

2024 · Zoltán Kiss, Tamás G. Szabó, et al. · Frontiers in Oncology · 6

PDF

Improving Quality Indicator of Melanoma Management – Change of Melanoma Mortality-to-Incidence Rate Ratio Based on a Hungarian Nationwide Retrospective Study

2021 · Máté Várnai, Zoltán Kiss, et al. · Frontiers in Oncology · 6

Increase in the Length of Lung Cancer Patient Pathway Before First-Line Therapy: A 6-Year Nationwide Analysis From Hungary

2021 · Zoltan Kiss, Krisztina Bogos, et al. · Pathology & Oncology Research · 5

PDF

Improvements in cancer survival in Hungary: a nationwide epidemiology study between 2011–2019 based on a health insurance fund database

2025 · Zoltán Kiss, Anikó Maráz, et al. · Frontiers in Oncology · 4

Overall Survival of Hungarian Cancer Patients Diagnosed Between 2011 and 2019, Based on the Health Insurance Fund Database

2025 · Zoltán Kiss, Tamás László Berki, et al. · Cancers · 3

PDF

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)

2022 · Zolta´n Kiss, Krisztina Bogos, et al. · Frontiers in Oncology · 3

PDF

Type 2 diabetes, cardiovascular disease and chronic kidney disease in Hungary: multimorbidity and 11-year survival in a nationwide retrospective study

2026 · Judit Annamaria Somogyi, Zoltán Vokó, et al. · BMJ Open

Cancer Diagnoses and Deaths in Hungary, 2011–2023: Nationwide Trends Before, During, and After the COVID-19 Pandemic

2026 · Zoltán Kiss, Tamás G. Szabó, et al. · Cancers

Burden of Community-acquired Pneumonia in Hungary: a Nationwide Analysis of Incidence, Hospitalization Rates, and Mortality Between 2016 and 2020

2026 · Zoltán Kiss, Zsófia Mészner, et al. · medRxiv

PDF

Revising Cancer Incidence in a Central European Country: A Hungarian Nationwide Epidemiology Study between 2011–2019 Based on a Health Insurance Fund Database

2024 · Zoltán Kiss, Tamás G. Szabó, et al. · SSRN Electronic Journal

Underlying reasons for post-mortem diagnosed lung cancer cases – A robust retrospective comparative study from Hungary (HULC study)

2022 · Zoltán Kiss, Krisztina Bogos, et al. · medRxiv

PDF

45P Analysis of lung cancer patient pathway: A 6-year nationwide analysis from Hungary

2021 · K. Bogos, G. Gaffly, et al. · Journal of Thoracic Oncology

PDF

Works count: 25

Citation count: 380

H-index: 9

I10-index: 9